Daiichi Says Court Should Decide Drug Patent Fight Venue
Daiichi Sankyo Co. Ltd. told a Delaware court Wednesday that it must decide whether its dispute with a U.S. biotechnology company over cancer drug patents must be arbitrated or litigated, saying...To view the full article, register now.
Already a subscriber? Click here to view full article